Back
Herc Holdings Vs. Blueprint Medicines Industry Stock Comparison
Buy
62
HRI
Herc Holdings
Last Price:
$205.00
Seasonality Move:
-8.58%
Sell
45
BPMC
Blueprint Medicines
Last Price:
$101.79
Seasonality Move:
3.52%
Buy
62
Herc Holdings (HRI)
is a Buy
Is Herc Holdings a Buy, Sell or Hold?
-
The current Herc Holdings [HRI] share price is $202.75. The Score for HRI is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
HRI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $104.00. The Score for BPMC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRI Stock Price Chart
What is Herc Holdings's stock price today?
-
The Herc Holdings share price today is $202.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRI is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $104.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.
HRI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.61 | Buy |
Relative Strength Index (14 RSI): | 50.61 | Buy |
Chaikin Money Flow: | -122742 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (190.04 - 209.14) | Buy |
Bollinger Bands (100): | (171.5 - 220.9) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.83 | Buy |
Relative Strength Index (14 RSI): | 46.48 | Sell |
Chaikin Money Flow: | 876303 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (97.11 - 115.03) | Sell |
Bollinger Bands (100): | (86.33 - 103.71) | Buy |
HRI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 204.54 | Sell |
20-day SMA: | 203.49 | Sell |
50-day SMA: | 203.53 | Sell |
200-day SMA: | 168.66 | Buy |
8-day EMA: | 204.35 | Sell |
20-day EMA: | 202.6 | Buy |
50-day EMA: | 200.71 | Buy |
200-day EMA: | 177.49 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.06 | Sell |
20-day SMA: | 110.08 | Sell |
50-day SMA: | 99.51 | Buy |
200-day SMA: | 98.69 | Buy |
8-day EMA: | 108.69 | Sell |
20-day EMA: | 107.48 | Sell |
50-day EMA: | 101.98 | Buy |
200-day EMA: | 94.86 | Buy |
Herc Holdings Earnings Growth & HRI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.79 per share, and an increase next year of $2.82 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $2.97 per share.
Herc Holdings Technical Analysis
Jan 28 | Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jan 28 | Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |